查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1878918

營養保健品CDMO市場－全球產業規模、佔有率、趨勢、機會和預測，依劑型、服務、公司規模、地區和競爭格局分類，2020-2030年預測

Nutraceuticals CDMO Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Dosage Form, By Service, By Company Size, By Region, and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 190 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024年全球營養保健品CDMO市場規模為351億美元，預計2030年將以7.90%的複合年成長率成長至553.9億美元。營養保健品是指源自食品，除提供基本營養外，還能帶來其他健康益處的產品，涵蓋膳食補充劑和功能性食品。全球營養保健品合約開發與生產組織（CDMO）市場正經歷強勁成長，主要促進因素包括消費者預防保健意識的提高、全球人口老化以及對特殊配方和複雜產品開發日益成長的需求。

市場概覽
預測期 2026-2030
2024年市場規模 351億美元
2030年市場規模 553.9億美元
2025-2030年複合年成長率 7.9%
成長最快的細分市場 片劑和膠囊
最大的市場 北美洲

主要市場促進因素

主要市場挑戰

主要市場趨勢

目錄

第1章：產品概述

第2章：研究方法

第3章：執行概要

第4章：客戶之聲

第5章：全球營養保健品CDMO市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按劑型（片劑和膠囊、粉末、軟膠囊、其他）
    • 依服務項目分類（產品配方及開發、生產及包裝、研發、法規遵循、其他）
    • 依公司規模分類（小型公司、中型公司、大型公司）
    • 按地區
    • 按公司（2024 年）
  • 市場地圖

第6章：北美營養保健品CDMO市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲營養保健品CDMO市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區營養保健品CDMO市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲營養保健品CDMO市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲營養保健品CDMO市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章：市場動態

  • 促進要素
  • 挑戰

第12章：市場趨勢與發展

  • 併購（如有）
  • 產品發布（如有）
  • 最新進展

第13章：全球營養保健品CDMO市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商議價能力
  • 顧客的力量
  • 替代產品的威脅

第15章：競爭格局

  • Catalent Inc.
  • Lonza Group AG
  • NUTRASCIENCE LABS Inc
  • Robinson Pharma, Inc.
  • Health Wright Products, Inc.
  • Innovations in Nutrition + Wellness
  • INPHARMA SpA
  • Aenova Group
  • NutraPak USA
  • SFI Health Pty Ltd.

第16章：策略建議

第17章調查會社について,免責事項

簡介目錄
Product Code: 17092

The Global Nutraceuticals CDMO Market, valued at USD 35.10 Billion in 2024, is projected to experience a CAGR of 7.90% to reach USD 55.39 Billion by 2030. Nutraceuticals are products derived from food sources that provide health benefits beyond basic nutrition, encompassing dietary supplements and functional foods. The global nutraceuticals Contract Development and Manufacturing Organization (CDMO) market experiences robust growth, primarily driven by increasing consumer awareness of preventative healthcare, an aging global population, and the escalating demand for specialized formulations and complex product development.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 35.10 Billion
Market Size 2030USD 55.39 Billion
CAGR 2025-20307.9%
Fastest Growing SegmentTablets & capsule
Largest MarketNorth America

Key Market Drivers

The global nutraceutical CDMO market is experiencing substantial expansion, primarily driven by the escalating consumer demand for health and wellness products, alongside an increasing trend of outsourcing manufacturing and development within the nutraceutical sector. Consumers are proactively seeking dietary solutions that offer benefits beyond basic nutrition, a behavior pattern reflected in specific market segments. For instance, according to the International Probiotics Association, in March 2024, the Asia Pacific region contributed USD 3.7 billion to global probiotic supplement sales in 2023, representing 42% of the total. This sustained demand for diverse and specialized nutraceuticals necessitates advanced manufacturing capabilities and formulation expertise many brands often lack internally.

Key Market Challenges

A significant challenge impeding the expansion of the Global Nutraceuticals CDMO Market is the stringent and constantly evolving global regulatory landscape. The necessity for CDMOs to continuously adapt and invest in compliance measures directly hampers market growth by increasing operational complexities and costs. This dynamic environment requires substantial resource allocation for staying abreast of diverse national and international regulations, including ingredient approvals, labeling requirements, and manufacturing standards.

Such continuous investment in regulatory expertise, quality systems, and facility upgrades to meet new guidelines leads to higher overheads, impacting pricing strategies and potentially reducing the competitiveness of CDMOs. For instance, according to the National Association of Manufacturers, in 2022, the average U. S. manufacturer paid over $29,000 per employee per year to comply with federal regulations, calculated in 2023 dollars. This financial burden elevates the barrier to entry for new CDMOs and poses an ongoing strain on existing players, thereby limiting overall market expansion as resources are diverted from innovation or capacity building towards compliance.

Key Market Trends

The increasing consumer demand for tailored health solutions is significantly driving the market through personalized nutrition and custom formulation capabilities. Nutraceutical CDMOs are adapting their development and manufacturing processes to produce bespoke products that cater to individual health profiles, genetic predispositions, and lifestyle choices. This shift necessitates flexible production lines, advanced ingredient sourcing, and expertise in diverse formulations to meet evolving consumer expectations for unique dietary support.

Key Market Players

  • Catalent Inc.
  • Lonza Group AG
  • NUTRASCIENCE LABS Inc
  • Robinson Pharma, Inc.
  • Health Wright Products, Inc.
  • Innovations in Nutrition + Wellness
  • INPHARMA S.p.A.
  • Aenova Group
  • NutraPak USA
  • SFI Health Pty Ltd.

Report Scope:

In this report, the Global Nutraceuticals CDMO Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Nutraceuticals CDMO Market, By Dosage Form:

  • Tablets & Capsules
  • Powder
  • Softgel
  • Others

Nutraceuticals CDMO Market, By Service:

  • Product Formulation and Development
  • Manufacturing and Packaging
  • Research & Development (R&D)
  • Regulatory Compliance
  • Others

Nutraceuticals CDMO Market, By Company Size:

  • Small Companies
  • Mid-Sized Companies
  • Large Companies

Nutraceuticals CDMO Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Nutraceuticals CDMO Market.

Available Customizations:

Global Nutraceuticals CDMO Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Nutraceuticals CDMO Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Dosage Form (Tablets & Capsules, Powder, Softgel, Others)
    • 5.2.2. By Service (Product Formulation and Development, Manufacturing and Packaging, Research & Development (R&D), Regulatory Compliance, Others)
    • 5.2.3. By Company Size (Small Companies, Mid-Sized Companies, Large Companies)
    • 5.2.4. By Region
    • 5.2.5. By Company (2024)
  • 5.3. Market Map

6. North America Nutraceuticals CDMO Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Dosage Form
    • 6.2.2. By Service
    • 6.2.3. By Company Size
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Nutraceuticals CDMO Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Dosage Form
        • 6.3.1.2.2. By Service
        • 6.3.1.2.3. By Company Size
    • 6.3.2. Canada Nutraceuticals CDMO Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Dosage Form
        • 6.3.2.2.2. By Service
        • 6.3.2.2.3. By Company Size
    • 6.3.3. Mexico Nutraceuticals CDMO Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Dosage Form
        • 6.3.3.2.2. By Service
        • 6.3.3.2.3. By Company Size

7. Europe Nutraceuticals CDMO Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Dosage Form
    • 7.2.2. By Service
    • 7.2.3. By Company Size
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Nutraceuticals CDMO Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Dosage Form
        • 7.3.1.2.2. By Service
        • 7.3.1.2.3. By Company Size
    • 7.3.2. France Nutraceuticals CDMO Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Dosage Form
        • 7.3.2.2.2. By Service
        • 7.3.2.2.3. By Company Size
    • 7.3.3. United Kingdom Nutraceuticals CDMO Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Dosage Form
        • 7.3.3.2.2. By Service
        • 7.3.3.2.3. By Company Size
    • 7.3.4. Italy Nutraceuticals CDMO Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Dosage Form
        • 7.3.4.2.2. By Service
        • 7.3.4.2.3. By Company Size
    • 7.3.5. Spain Nutraceuticals CDMO Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Dosage Form
        • 7.3.5.2.2. By Service
        • 7.3.5.2.3. By Company Size

8. Asia Pacific Nutraceuticals CDMO Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Dosage Form
    • 8.2.2. By Service
    • 8.2.3. By Company Size
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Nutraceuticals CDMO Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Dosage Form
        • 8.3.1.2.2. By Service
        • 8.3.1.2.3. By Company Size
    • 8.3.2. India Nutraceuticals CDMO Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Dosage Form
        • 8.3.2.2.2. By Service
        • 8.3.2.2.3. By Company Size
    • 8.3.3. Japan Nutraceuticals CDMO Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Dosage Form
        • 8.3.3.2.2. By Service
        • 8.3.3.2.3. By Company Size
    • 8.3.4. South Korea Nutraceuticals CDMO Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Dosage Form
        • 8.3.4.2.2. By Service
        • 8.3.4.2.3. By Company Size
    • 8.3.5. Australia Nutraceuticals CDMO Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Dosage Form
        • 8.3.5.2.2. By Service
        • 8.3.5.2.3. By Company Size

9. Middle East & Africa Nutraceuticals CDMO Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Dosage Form
    • 9.2.2. By Service
    • 9.2.3. By Company Size
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Nutraceuticals CDMO Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Dosage Form
        • 9.3.1.2.2. By Service
        • 9.3.1.2.3. By Company Size
    • 9.3.2. UAE Nutraceuticals CDMO Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Dosage Form
        • 9.3.2.2.2. By Service
        • 9.3.2.2.3. By Company Size
    • 9.3.3. South Africa Nutraceuticals CDMO Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Dosage Form
        • 9.3.3.2.2. By Service
        • 9.3.3.2.3. By Company Size

10. South America Nutraceuticals CDMO Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Dosage Form
    • 10.2.2. By Service
    • 10.2.3. By Company Size
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Nutraceuticals CDMO Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Dosage Form
        • 10.3.1.2.2. By Service
        • 10.3.1.2.3. By Company Size
    • 10.3.2. Colombia Nutraceuticals CDMO Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Dosage Form
        • 10.3.2.2.2. By Service
        • 10.3.2.2.3. By Company Size
    • 10.3.3. Argentina Nutraceuticals CDMO Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Dosage Form
        • 10.3.3.2.2. By Service
        • 10.3.3.2.3. By Company Size

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Nutraceuticals CDMO Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Catalent Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Lonza Group AG
  • 15.3. NUTRASCIENCE LABS Inc
  • 15.4. Robinson Pharma, Inc.
  • 15.5. Health Wright Products, Inc.
  • 15.6. Innovations in Nutrition + Wellness
  • 15.7. INPHARMA S.p.A.
  • 15.8. Aenova Group
  • 15.9. NutraPak USA
  • 15.10. SFI Health Pty Ltd.

16. Strategic Recommendations

17. About Us & Disclaimer